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Characterisation of macrophages infiltrating human
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It is well established that most malignant tumours
contain a variable number of macrophages (Evans,
1977; Russell et al., 1981), but their presence in
human breast cancer has been poorly documented.
Although Wood & Gollahon (1977) demonstrated
Fc(IgG) receptor-bearing cells in breast tumours,
some investigators believe that malignant cells can
express such receptors (Tonder & Thunold, 1973;
Svennevig & Andersson, 1982). Morphologically,
macrophages are not readily delineated in tissue
sections of carcinomas, and in tumour cell
suspensions precise identification is likewise
difficult. This necessitates the use of cell markers,
and in the present study, macrophages were
identified by their ability to express receptors for
Fc(IgG) and C3 and to possess HLA-DR antigens.
In order to characterise these cells more precisely, a
monoclonal antibody reactive with a
myelomonocytic antigen (Kraft et al., 1979) and a
polyclonal antibody reactive with epithelial
membrane antigen (EMA) (Heyderman et al.,
1979), were also employed.
Thirteen women with histologically confirmed
primary invasive mammary carcinoma, clinically
confined to the breast and axilla were studied. A
portion of the carcinoma removed at operation was
cleared of fat and fascia and washed in tissue
culture medium (TCM). TCM consisted of RPMI-
1640 (Gibco, Europe) with 10% heat-inactivated
foetal calf serum, streptomycin (100ugml-1),
penicillin G (100,000i.u.ml-1), 0.7g sodium
bicarbonate 1-1 and 25mM HEPES buffer. The
tumour specimen was diced in TCM, and the pieces
incubated in 15mls collagenase (Sigma, Type I,
300Uml-1-dissolved in TCM without serum) at
37°C for 12h with occasional agitation. The cell
suspension was filtered through sterile gauze layers
and washed six times in TCM to remove residual
debris and tissue fragments. The cells were then
resuspended in TCM at 2 x 106mI-1, and cell
numbers and viability were assessed using phase
contrast microscopy (Eremin et al., 1982).
Four surface markers were studied: the receptors
for the Fc portion of IgG and for C3, HLA-DR
antigen, identified by the mouse monoclonal
antibody BT2/9, and a macrophage-associated
antigen defined by the mouse monoclonal antibody
VEP-7. Fc(IgG) receptors were detected by means
of the EA-rosetting reaction. Briefly, ox
erythrocytes (E), were incubated with a
subagglutinating but optimal dose of rabbit IgG
anti-ox erythrocyte antiserum (A) (1:100 in PBS)
for 45min at room temperature (RT) (Eremin et
al., 1976). The sensitised EA indicator cells (2%
suspension in TCM) were mixed with equal
volumes of the tumour cell suspensions
(2 x 0l6cellsml-1) and spun down. The pellet was
allowed to stand at 4°C for 30min and then
resuspended by slow, continuous rotation for 1 min.
C3 receptors were demonstrated using the EAC-
rosetting reaction. Ox erythrocytes (E) were
incubated with a subagglutinating but optimal dose
of rabbit IgM anti-ox erythrocyte antibody (A)
(1:40 in PBS) for 15min at 4°C and then with an
equal volume of C5 deficient mouse serum (1:10 in
complement fixation test diluent) for 15min at
37°C (Eremin et al., 1976). The sensitised EAC
indicators were then used in rosetting reactions as
described above. Appropriate controls (heat-
inactivated complement, EA-IgM) were set up and
found to be negative. Fc(IgM) activity was absent
in TCM (Eremin et al., 1982). The HLA-DR
antigen and the macrophage-associated antigen
were detected by the direct antiglobulin rosetting
reaction (DARR), as detailed previously (Coombs
et al., 1977). In this assay, the appropriate antibody
was coupled, using 0.02% chromic chloride to
trypsin-treated sheep erythrocytes. The latter were
slowly rotated at RT for 60min, washed in PBS,
made up to a 1% suspension in PBS and stored at
4°C. The efficacy of the coupling was checked by a
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reverse passive haemagglutination test using rabbit
anti-mouse immunoglobulin antibody (Dako). The
cells to be tested (2 x 106ml-1 in PBS) were mixed
with an equal volume of indicator cells, spun down
and allowed to stand at 4°C for 30min.
Cytocentrifuge preparations of the rosetted cell
suspensions were made and fixed in absolute
ethanol for exactly 5min. To detect cells expressing
epithelial membrane antigen (EMA) in these
preparations, the peroxidase-antiperoxidase method
was used (Burns, 1975). A rabbit anti-human EMA
antibody, diluted 1:400 in 5ml of Tris-buffered
saline containing 2% normal swine serum, was
employed as the primary antibody, followed by a
swine anti-rabbit immunoglobulin (Dako), and then
by rabbit immunoglobulin against horseradish
peroxidase conjugated with peroxidase (Dako). The
distinctive reddish-brown colour, indicating the
presence of the peroxidase, was produced by 3-
amino 9-ethylcarbazole, diluted 1:10 with acetate
buffer and one drop of 30vol H202. The slides were
incubated in this reagent for 5min at RT and
counterstained using haematoxylin. On each
of the immunoperoxidase-stained cytocentrifuge
preparations, 100 non-lymphocytic cells (assessed
morphologically) were counted and the number
rosetting was noted; the numbers of EMA-positive
cells in the rosetted and non-rosetted populations
were also recorded.
In order to assess the effect of collagenase in the
preparative technique used to isolate the tumour
macrophages, 1 x 107 mononuclear cells isolated on
Ficoll-Hypaque from the blood of 10 healthy
volunteers were incubated with 15 ml of collagenase
for 12h, washed six times in TCM and
Table II Percentage of cells e)
and
resuspended. Cell numbers and viability were
assessed and the monocyte surface receptor-markers
were then determined, as outlined above, on treated
and non-treated cells.
The percentages of non-lymphocytic cells (15 to
40pm) displaying Fc (IgG) receptors, HLA-DR
antigens and VEP-7-defined antigens were
substantial and comparable (Table I). C3 receptor
expression, however, was less prevalent - see below
and Eremin et al. (1982). Rosette-forming cells (>5
red blood cells attached to mononuclear cells)
rarely stained for EMA (0-4%). A variable but
significant number of non-rosetting cells, on the
other hand, stained for EMA (Table II). A
substantial number of cells lacked macrophage
characteristics and EMA, probably reflecting
differential expression of the latter and the presence
of stromal (non epithelial) cells. With all four
Table I Percentage of macrophages in human breast
tumour cell preparations
% Cells in breast tumour
Macrophage preparations expressing
receptor-marker receptor-markera b
Fc(IgG) receptor 36.2+15.1 (15-59)
C3 receptor 20.7+ 11.2 (4-40)
HLA-DR antigen 40.8+11.8 (22-60)
VEP-7 antigenc 39.7+13.9 (19-64)
aBreast tumour cell suspensions obtained by digestion of
tumour pieces with collagenase (see Text).
bValues expressed as mean+standard deviation (range)
CVEP-7 antigen: myelomonocyte-associated antigen de-
tected by mouse monoclonal antibody (Kraft et al., 1979).
xpressing surface receptor-markers
EMA
% Cells in breast tumourpreparations
expressing receptor-marker and EMAa
Surface
receptor-marker EMA + EMA -
Fc(IgG)+ 0.3+ 0.6 (0-4) 35.9+14.9 (15-59)
Fc(IgG)- 20.6+ 13.5 (3-47) 42.2+ 13.6 (24-78)
C3 0 20.7+ 11.2 (4_40)b
C3- 20.4+11.1 (3-38) 59.7+ 9.9 (41-80)
HLA-DR+ 0.2+ 0.4 (0-4) 40.7+11.6 (22-60)
HLA-DR- 17.5+12.9 (0-40) 41.6+ 13.7 (18-74)
VEP-7+ 0.5+ 0.7(0-2) 39.2+13.9(19-64)
VEP-7- 18.6+12.1 (3-43) 41.2+13.6 (18-73)
aValues expressed as mean +standard deviation (range).
bLow level of C3 receptor-bearing subset due to removal or
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assays, the asociation between EMA and the
absence of rosette-forming ability was highly
significant by Cox's precedure for combining
several regressions which have a binary response
(Cox, 1970). It should be noted that in the few
cases where rosetted cells were positive for EMA,
the staining exhibited a characteristic pattern,
suggesting previous phagocytosis of EMA positive
particles, rather than the diffuse cytoplasmic
distribution seen in non-rosetted cells.
Phagocytosis of red cells was noted on the
cytocentrifuge preparations in 5-15% of the
Fc(IgG) receptor-positive cells. Prior incubation of
these cells at 37°C for 2h however, led to a marked
increase in the incidence of phagocytosis, and
ingested erythrocytes were seen in 20-60% of
rosetted cells.
Pre-incubation of blood monocytes with
collagenase did not markedly alter the expression of
Fc(IgG) receptors, HLA-DR antigens or VEP-7-
defined antigen expression. EAC rosette formation,
however, was inhibited, indicating that C3 receptors
were stripped off or altered by the collagenase
preparation. The latter contained small amounts of
trypsin which is known to modify the surface
receptor for C3 (Henson, 1969), although
prolonged incubation at 37°C can lead to re-
expression of the receptor (Eremin et al., 1982).
Only small, nonspecific cell losses occurred during
incubation with collagenase (Eremin et al., 1982).
This study has shown that human breast cancers
contain a substantial population of non-
lymphocytic, medium to large (15 to 40,pm) cells
bearing Fc(IgG) receptors, C3 receptors, HLA-DR
and macrophage-associated antigens. Macrophages
are known to bear Fc(IgG) receptors (Berken &
Benacerraf, 1966; Nelson, 1981) and to express
HLA-DR antigens (Hirchberg et al., 1976).
Morphologically, the rosetting cells in the present
study resembled macrophages and a variable
percentage contained phagocytosed indicator red
blood cells. In addition, the numbers of cells
displaying Fc(IgG) receptors and HLA-DR antigen
were comparable to the numbers bearing the VEP-
7-defined antigen, suggesting that these cells were
macrophages. The C3 receptor-bearing cells,
however, were fewer in number than the VEP-7-
positive cells, a phenomenon probably due to
removal or alteration of the glycoprotein receptor
for C3 by trypsin in the collagenase preparation.
Thus, in view of the documented presence of C3
receptors on macrophages (Huber et al., 1968;
Nelson, 1981), the morphological appearance of the
rosetting cells and the observed phagocytosis of the
EAC cells, the C3 receptor-positive cells isolated
from the tumours were probably also macrophages.
These observations alone, however, do not
establish unequivocally that the cells bearing Fc or
C3 receptors and HLA-DR antigens are
macrophages. Although the Fc(IgG) receptor has
been widely used as a macrophage marker in
tumour cell suspensions (Russell et al., 1981), some
workers have suggested that malignant cells
themselves may express Fc(IgG) receptors (Tonder
& Thunold, 1973; Svennevig & Andersson, 1982).
In addition, it has been shown that human
monocytes can shed these receptors in culture (Kay
& Douglas, 1981), raising the possibility of non-
specific receptor uptake by tumour cells. HLA-DR
antigens are certainly found on macrophages and
other antigen-presenting cells, but some lymphocyte
subsets also display them (Barclay & Mason, 1983).
A previous study, however, has documented low
numbers only of activated T cells and B
lymphoblasts within breast carcinomas (Eremin et
al., 1982), suggesting that these cells are an unlikely
source of error. Recently some workers have
demonstrated HLA-DR antigens in tissue sections
of human tumours (Natali et al., 1981; Gatter et
al., 1982), but in these reports, no attempt was
made to differentiate the tumour-infiltrating
macrophages from the neoplastic cells.
The present study, on the other hand, has
established that the malignant cells in the breast
tumour cell suspensions studied did not express the
receptors-markers employed to characterise
macrophages. Rabbit anti human EMA
(Heyderman et al., 1979), was used to identify
epithelial cells in cytocentrifuge preparations of
breast tumour cell suspensions in which
macrophages were delineated by rosette formation.
EMA is expressed by nearly all breast cancers
(Dearnaley et al., 1981), but it is not present on all
cells within a single tumour (Heyderman et al.,
1979) and it is not exclusive to neoplastic cells.
EMA is only expressed by epithelial cells, however
(Sloane & Ormerod, 1981), and in suspensions from
breast cancers, EMA positive cells can be assumed
to be neoplastic.
In summary, this study has shown firstly that
human breast carcinomas contain substantial,
although variable, numbers of macrophages (19-
64%). Secondly the study suggests that the majority
of these tumour-infiltrating macrophages express
Fc(IgG) and C3 receptors and HLA-DR antigens.
Finally, using an antibody reactive with EMA, it
has been demonstrated that breast carcinoma cells
lack these macrophage receptor-markers.
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